This forum highlights the impact of funding cuts on US biomedical innovation, suggesting rising competition from China.
This JAMA Forum discusses challenges to the US’s standing as a global leader in biomedical innovation from China, in the context of recent reductions in funding for biomedical research by the federal government.
No takes yet. Share an insight, caveat, or question.
Scott Gottlieb (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: